SMTL ID : 9inu.1

Novel PD-L1/VISTA dual inhibitor as potential immunotherapy agents

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

homo-dimer

Ligands

1 x 01: (2~{S})-2-[[6-methoxy-2-[(2-methyl-3-phenyl-phenyl)amino]pyrimidin-4-yl]methylamino]-3-oxidanyl-propanoic acid

01.1: 19 residues within 4Å: Chain A: I.37, Y.39, Q.49, V.51, M.98, I.99, S.100, A.104, D.105 Chain B: A.1, F.2, I.37, Y.39, M.98, I.99, S.100, A.104, D.105, Y.106 14 PLIP interactions: 7 interactions with chain A, 7 interactions with chain B Hydrophobic interactions: A:I.37, A:Y.39, A:M.98, A:A.104, B:I.37, B:M.98, B:A.104, B:Y.106 Hydrogen bonds: A:Q.49, A:Q.49, B:F.2, B:D.105 pi-Stacking: A:Y.39, B:Y.39

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sun, C. et al., Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents. J.Med.Chem. (2025)

Release Date

2025-03-12

Peptides

Programmed cell death 1 ligand 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Programmed cell death 1 ligand 1

Related Entries With Identical Sequence